Ayrton Capital LLC 13D/13G Filings for Cocrystal Pharma, Inc. (COCP)

Ayrton Capital LLC 13D and 13G filings for Cocrystal Pharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-05-17
5:13 pm
Purchase
2021-05-0513GCocrystal Pharma, Inc.
COCP
Ayrton Capital LLC543,333
6.690%
543,333increase
(New Position)
Filing